Literature DB >> 21955519

Social stress promotes and γ-aminobutyric acid inhibits tumor growth in mouse models of non-small cell lung cancer.

Hussein A N Al-Wadei1, Howard K Plummer, Mohammad F Ullah, Benjamin Unger, Joel R Brody, Hildegard M Schuller.   

Abstract

Psychologic distress is associated with increased lung cancer incidence and mortality. We have shown that non-small cell lung cancer (NSCLC) cells in vitro are stimulated by the cyclic AMP (cAMP)-dependent activation of cAMP-responsive element binding protein (CREB) and extracellular signal-regulated kinase (ERK) downstream of β-adrenergic receptors and that this pathway is inhibited by the neurotransmitter γ-aminobutyric acid (GABA). Because the stress neurotransmitters noradrenalin and adrenalin are β-adrenergic agonists, the current study has tested the hypothesis that social stress stimulates NSCLC growth in vivo and that GABA inhibits this effect. Social stress was induced in mice carrying xenografts from two NSCLC cell lines in the presence and absence of treatment with GABA. Xenograft sizes were measured after 30 days. Noradrenalin, adrenalin, cortisol, GABA, and cAMP were measured in blood and tumor tissues by immunoassays. Expression of nicotinic receptors in the xenografts was assessed by real-time PCR and Western blotting. Protein expression of phospho (p)-CREB, CREB, phospho (p)-ERK, ERK, and glutamate decarboxylase (GAD) 65 and 67 were determined by Western blotting. Xenograft sizes in stress-exposed mice were significantly increased. Nicotinic acetylcholine receptor (nAChR) subunits α3, α4, α5, and α7 in xenograft tissues showed posttranscriptional induction. Noradrenalin, adrenalin, and cortisol were elevated in serum and xenograft tissue whereas GABA was suppressed. Levels of cAMP, p-CREB, and p-ERK were increased whereas GAD65 and GAD67 were suppressed in tumor tissue. Treatment with GABA reversed the effects of stress. Our findings suggest that social stress stimulates NSCLC by increasing nAChR-mediated stress neurotransmitter signaling and that GABA is a promising novel agent for NSCLC intervention. ©2011 AACR.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21955519      PMCID: PMC3320046          DOI: 10.1158/1940-6207.CAPR-11-0177

Source DB:  PubMed          Journal:  Cancer Prev Res (Phila)        ISSN: 1940-6215


  41 in total

1.  Ethnic and racial differences in the smoking-related risk of lung cancer.

Authors:  Christopher A Haiman; Daniel O Stram; Lynne R Wilkens; Malcolm C Pike; Laurence N Kolonel; Brian E Henderson; Loïc Le Marchand
Journal:  N Engl J Med       Date:  2006-01-26       Impact factor: 91.245

2.  Stress hormone-mediated invasion of ovarian cancer cells.

Authors:  Anil K Sood; Robert Bhatty; Aparna A Kamat; Charles N Landen; Liz Han; Premal H Thaker; Yang Li; David M Gershenson; Susan Lutgendorf; Steven W Cole
Journal:  Clin Cancer Res       Date:  2006-01-15       Impact factor: 12.531

3.  alpha3alpha5beta2-Nicotinic acetylcholine receptor contributes to the wound repair of the respiratory epithelium by modulating intracellular calcium in migrating cells.

Authors:  Jean-Marie Tournier; Kamel Maouche; Christelle Coraux; Jean-Marie Zahm; Isabelle Cloëz-Tayarani; Béatrice Nawrocki-Raby; Arnaud Bonnomet; Henriette Burlet; François Lebargy; Myriam Polette; Philippe Birembaut
Journal:  Am J Pathol       Date:  2006-01       Impact factor: 4.307

4.  NNK activates ERK1/2 and CREB/ATF-1 via beta-1-AR and EGFR signaling in human lung adenocarcinoma and small airway epithelial cells.

Authors:  E Laag; M Majidi; M Cekanova; T Masi; T Takahashi; H M Schuller
Journal:  Int J Cancer       Date:  2006-10-01       Impact factor: 7.396

5.  The norepinephrine-driven metastasis development of PC-3 human prostate cancer cells in BALB/c nude mice is inhibited by beta-blockers.

Authors:  Daniel Palm; Kerstin Lang; Bernd Niggemann; Theodore L Drell; Kai Masur; Kurt S Zaenker; Frank Entschladen
Journal:  Int J Cancer       Date:  2006-06-01       Impact factor: 7.396

6.  PKA-dependent growth stimulation of cells derived from human pulmonary adenocarcinoma and small airway epithelium by dexamethasone.

Authors:  H A N Al-Wadei; T Takahasi; H M Schuller
Journal:  Eur J Cancer       Date:  2005-10-18       Impact factor: 9.162

7.  Nicotine promotes cell proliferation via alpha7-nicotinic acetylcholine receptor and catecholamine-synthesizing enzymes-mediated pathway in human colon adenocarcinoma HT-29 cells.

Authors:  Helen Pui Shan Wong; Le Yu; Emily Kai Yee Lam; Emily Kin Ki Tai; William Ka Kei Wu; Chi Hin Cho
Journal:  Toxicol Appl Pharmacol       Date:  2007-04-12       Impact factor: 4.219

8.  GABA B receptor is a novel drug target for pancreatic cancer.

Authors:  Hildegard M Schuller; Hussein A N Al-Wadei; Mourad Majidi
Journal:  Cancer       Date:  2008-02-15       Impact factor: 6.860

9.  Nongenomic beta estrogen receptors enhance beta1 adrenergic signaling induced by the nicotine-derived carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in human small airway epithelial cells.

Authors:  Mourad Majidi; Hussein A Al-Wadei; Takashi Takahashi; Hildegard M Schuller
Journal:  Cancer Res       Date:  2007-07-15       Impact factor: 12.701

10.  Expression of G-protein inwardly rectifying potassium channels (GIRKs) in lung cancer cell lines.

Authors:  Howard K Plummer; Madhu S Dhar; Maria Cekanova; Hildegard M Schuller
Journal:  BMC Cancer       Date:  2005-08-18       Impact factor: 4.430

View more
  30 in total

1.  Differences in clinical presentation of non-small cell lung cancer in never-smokers versus smokers.

Authors:  Joo Young Lee; Im Ii Na; Seung-Hun Jang; Yong Il Hwang; Du Hwan Choe; Cheol Hyeon Kim; Heejong Baek
Journal:  J Thorac Dis       Date:  2013-12       Impact factor: 2.895

2.  Repurposing established cyclic adenosine monophosphate reducing agents for the prevention and therapy of epidermal growth factor receptor inhibitor resistance in non-small cell lung cancer.

Authors:  Hildegard M Schuller
Journal:  Transl Lung Cancer Res       Date:  2018-04

3.  Beta-adrenergic signaling in the development and progression of pulmonary and pancreatic adenocarcinoma.

Authors:  Hildegard M Schuller; Hussein A N Al-Wadei
Journal:  Curr Cancer Ther Rev       Date:  2012-05-01

4.  Prenatal stress enhances NNK-induced lung tumors in A/J mice.

Authors:  Tomoaki Ito; Harumi Saeki; Xin Guo; Polina Sysa-Shah; Jonathan Coulter; Kellie L K Tamashiro; Richard S Lee; Hajime Orita; Koichi Sato; Shun Ishiyama; Alicia Hulbert; William E Smith; Lisa A Peterson; Malcolm V Brock; Kathleen L Gabrielson
Journal:  Carcinogenesis       Date:  2020-12-31       Impact factor: 4.944

5.  Stress hormones promote EGFR inhibitor resistance in NSCLC: Implications for combinations with β-blockers.

Authors:  Monique B Nilsson; Huiying Sun; Lixia Diao; Pan Tong; Diane Liu; Lerong Li; Youhong Fan; Alissa Poteete; Seung-Oe Lim; Kathryn Howells; Vincent Haddad; Daniel Gomez; Hai Tran; Guillermo Armaiz Pena; Lecia V Sequist; James C Yang; Jing Wang; Edward S Kim; Roy Herbst; J Jack Lee; Waun Ki Hong; Ignacio Wistuba; Mien-Chie Hung; Anil K Sood; John V Heymach
Journal:  Sci Transl Med       Date:  2017-11-08       Impact factor: 17.956

6.  Gamma-amino butyric acid (GABA) prevents the induction of nicotinic receptor-regulated signaling by chronic ethanol in pancreatic cancer cells and normal duct epithelia.

Authors:  Mohammed H Al-Wadei; Hussein A N Al-Wadei; Hildegard M Schuller
Journal:  Cancer Prev Res (Phila)       Date:  2012-12-04

Review 7.  Effects of tobacco constituents and psychological stress on the beta-adrenergic regulation of non-small cell lung cancer and pancreatic cancer: implications for intervention.

Authors:  Hildegard M Schuller
Journal:  Cancer Biomark       Date:  2013       Impact factor: 4.388

8.  Effects on DNA Damage and/or Repair Processes as Biological Mechanisms Linking Psychological Stress to Cancer Risk.

Authors:  Frank J Jenkins; Bennett Van Houten; Dana H Bovbjerg
Journal:  J Appl Biobehav Res       Date:  2014-02-01

9.  Improved survival outcomes with the incidental use of beta-blockers among patients with non-small-cell lung cancer treated with definitive radiation therapy.

Authors:  H M Wang; Z X Liao; R Komaki; J W Welsh; M S O'Reilly; J Y Chang; Y Zhuang; L B Levy; C Lu; D R Gomez
Journal:  Ann Oncol       Date:  2013-01-08       Impact factor: 32.976

Review 10.  β-Adrenergic Signaling in Lung Cancer: A Potential Role for Beta-Blockers.

Authors:  Monique B Nilsson; Xiuning Le; John V Heymach
Journal:  J Neuroimmune Pharmacol       Date:  2019-12-11       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.